Chinese Covid-19 vaccine found 79% effective in late stage trial

Date:

A Chinese inactivated vaccine shows 79.34 percent efficacy against COVID-19, according to the interim results of the phase-3 clinical trials unveiled by its developer on Wednesday.

The inactivated vaccine has been developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), which is affiliated to Sinopharm, Xinhua news agency reported.

After a two-dose inoculation procedure, the vaccine receivers all produced high titers of antibodies, and the seroconversion rate of neutralizing antibodies reached 99.52 percent.

The results meet the requirements of technical standards of the World Health Organization and the standards stipulated by China’s National Medical Products Administration (NMPA).

The company has submitted an application to the Chinese regulator for conditional market approval.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

spot_img

Popular

More like this
Related

“Anil Ravipudi Drops Exciting Updates on His Film with Chiranjeevi!”

Director Anil Ravipudi, known as one of the most...

“Box Office Storm: 8 Days of Sankranthi Magic!”

The sensational blockbuster Sankranthiki Vastunnam, directed by Anil Ravipudi...

“All Set for Dulquer’s Entry in Anupama’s ‘Parada’ Journey!”

The shooting for the much-awaited film Parada, featuring the...

‘Vishwambhara’ OTT Plans: Impact of ‘OG’

Mega hero fans are eagerly awaiting a much-needed blockbuster....